These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34148961)

  • 1. Implications of Doppler Echocardiography-guided Heart Rate Modulation Using Ivabradine.
    Hori M; Imamura T; Narang N; Kinugawa K
    Intern Med; 2021 Dec; 60(24):3873-3877. PubMed ID: 34148961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doppler Echocardiography-Guided Heart Rate Modulation Therapy Using Ivabradine in a Patient with Systolic Heart Failure.
    Imamura T; Kinugawa K
    Medicina (Kaunas); 2022 Jan; 58(2):. PubMed ID: 35208489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Doppler echocardiography-guided ivabradine therapy.
    Izumida T; Imamura T; Kinugawa K
    Heart Vessels; 2023 Jan; 38(1):49-55. PubMed ID: 35789418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Implications of Ivabradine in the Contemporary Era.
    Imamura T
    Medicina (Kaunas); 2024 Feb; 60(2):. PubMed ID: 38399590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to consider target heart rate in patients with systolic heart failure.
    Izumida T; Imamura T; Nakamura M; Fukuda N; Kinugawa K
    ESC Heart Fail; 2020 Oct; 7(5):3231-3234. PubMed ID: 32592292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal Heart Rate Modulation Using Ivabradine.
    Imamura T; Kinugawa K
    Int Heart J; 2021 Jul; 62(4):717-721. PubMed ID: 34276025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Implications of Mitral Valve Inflow Pattern Overlap during Ivabradine Therapy.
    Imamura T; Hori M; Narang N; Besser S; Kinugawa K
    Int Heart J; 2022; 63(1):43-48. PubMed ID: 35095075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implication of heart rate optimization in patients with heart failure.
    Hori M; Imamura T; Kinugawa K
    J Cardiol Cases; 2021 Apr; 23(4):163-165. PubMed ID: 33841593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Ivabradine on Heart Rate and Duration of Exercise in Patients With Mild-to-Moderate Mitral Stenosis: A Randomized Comparison With Metoprolol.
    Saggu DK; Narain VS; Dwivedi SK; Sethi R; Chandra S; Puri A; Saran RK
    J Cardiovasc Pharmacol; 2015 Jun; 65(6):552-4. PubMed ID: 25636072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of If-channel inhibition on hemodynamic status and exercise tolerance in heart failure with preserved ejection fraction: a randomized trial.
    Kosmala W; Holland DJ; Rojek A; Wright L; Przewlocka-Kosmala M; Marwick TH
    J Am Coll Cardiol; 2013 Oct; 62(15):1330-8. PubMed ID: 23916925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to Estimate the Optimal Heart Rate in Patients with Heart Failure with Preserved Ejection Fraction.
    Izumida T; Imamura T; Fukui T; Koi T; Ueno Y; Hori M; Nakagaito M; Tanaka S; Kataoka N; Ushijima R; Nakamura M; Sobajima M; Fukuda N; Ueno H; Kinugawa K
    Int Heart J; 2021 Jul; 62(4):816-820. PubMed ID: 34276013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implication of Ivabradine Therapy in Up-Titrating Beta-Blocker Dose in Patients with Systolic Dysfunction.
    Imamura T; Onoda H; Uchida K; Kinugawa K
    Int Heart J; 2021 Nov; 62(6):1305-1309. PubMed ID: 34744149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ivabradine in patients with heart failure with preserved ejection fraction: the EDIFY randomized placebo-controlled trial.
    Komajda M; Isnard R; Cohen-Solal A; Metra M; Pieske B; Ponikowski P; Voors AA; Dominjon F; Henon-Goburdhun C; Pannaux M; Böhm M;
    Eur J Heart Fail; 2017 Nov; 19(11):1495-1503. PubMed ID: 28462519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ivabradine for Treatment of Heart Failure with Preserved Ejection Fraction].
    Babushkina GV; Shaikhlislamova GI
    Kardiologiia; 2020 Oct; 60(10):33-37. PubMed ID: 33228503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic effects of Ivabradine in addition to dobutamine in patients with severe systolic dysfunction.
    Gallet R; Ternacle J; Damy T; Guendouz S; Bremont C; Seemann A; Gueret P; Dubois-Rande JL; Lim P
    Int J Cardiol; 2014 Sep; 176(2):450-5. PubMed ID: 25129291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ivabradine therapy on heart failure biomarkers.
    Ordu S; Yildiz BS; Alihanoglu YI; Ozsoy A; Tosun M; Evrengul H; Kaftan HA; Ozhan H
    Cardiol J; 2015; 22(5):501-9. PubMed ID: 25733317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ivabradine and Bisoprolol on Doppler-derived Coronary Flow Velocity Reserve in Patients with Stable Coronary Artery Disease: Beyond the Heart Rate.
    Tagliamonte E; Cirillo T; Rigo F; Astarita C; Coppola A; Romano C; Capuano N
    Adv Ther; 2015 Aug; 32(8):757-67. PubMed ID: 26293212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.
    Fox K; Ford I; Steg PG; Tendera M; Ferrari R;
    Lancet; 2008 Sep; 372(9641):807-16. PubMed ID: 18757088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ivabradine treatment in a chronic heart failure patient cohort: symptom reduction and improvement in quality of life in clinical practice.
    Zugck C; Martinka P; Stöckl G
    Adv Ther; 2014 Sep; 31(9):961-74. PubMed ID: 25160945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study.
    Böhm M; Borer J; Ford I; Gonzalez-Juanatey JR; Komajda M; Lopez-Sendon J; Reil JC; Swedberg K; Tavazzi L
    Clin Res Cardiol; 2013 Jan; 102(1):11-22. PubMed ID: 22575988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.